Hydroxyzine Hydrochloride
- Product NDC
- 71335-3035
- Requested package NDC
- 71335-3035-1
- 11-digit product format
- 713353035
- Labeler code
- 71335
- Product ID
- 71335-3035_73236eaf-d2da-4b4d-aa43-6c38d71a6ca3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Hydroxyzine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA087871
- Marketing category
- ANDA
- Marketing start
- 2021-10-07
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC], Histamine Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A087871-001 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 1982-12-20 | |
| A087871-002 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 1982-12-20 | |
| A087871-003 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 1982-12-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A087871-001 | AB |
| A087871-002 | AB |
| A087871-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A087871-001 | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | 1982-12-20 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A087871-002 | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 1982-12-20 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A087871-003 | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 1982-12-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A087871-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A087871-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A087871-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | f84e3365-57d2-4904-9275-96600f8d74c7 | 2026-06-22 | Warnings, Adverse reactions | 087871 ANDA087871 71335-3035-1 71335-3035 71335303501 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Aurobindo Pharma Limited | 9de2de56-614f-4294-8794-d30758cf5f70 | 2026-03-03 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 56b49e5c-bb8a-46cd-873c-3c743d1653a4 | 2026-02-17 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 3526a66b-2182-4b5a-a7d1-563d75f5335f | 2025-12-03 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 9504897e-febc-4293-a2dc-9f79f55ea821 | 2025-12-03 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | eef36dab-c318-44d2-8583-7bae3bfceee7 | 2025-10-13 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | American Health Packaging | fc148d96-b868-4e45-b7d2-977faf431049 | 2025-09-15 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | e4e6a91d-f10b-4d85-a526-4c6192ea85dc | 2025-05-23 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | a8c83479-f919-49f9-b125-747bd0e3211c | 2025-05-23 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 7c959515-a5a9-4d5e-90e9-bd58bc947330 | 2025-05-23 | Warnings, Adverse reactions | 087871 ANDA087871 |
| Hydroxyzine Hydrochloride | HYDROXYZINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | 138ec5c1-bb06-2a82-e063-6394a90ab42b | 2024-05-17 | Warnings, Adverse reactions | 087871 ANDA087871 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Hydroxyzine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE HYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995258 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f84e3365-57d2-4904-9275-96600f8d74c7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 57311cfb-679a-da1a-b70c-8757f7fc431a | Product name | 4 | 20250516 |
| aa1826f4-97c1-4705-bdf0-3bc7d234e618 | Product name | 2 | 20190618 |
| 75cb12ee-8eb2-4f1a-a332-5743a5d0da41 | Product name | 1 | 20151110 |
| 3ca5f78b-43dc-30fe-8014-55b922af52b3 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-3035-1 | Hydroxyzine Hydrochloride | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-3035-1 | EA - Each | 71335-3035 | e8fc8ba2-9fbd-46b1-8530-25dd23fdf46c | 1 | 2026-01-08 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995258 | hydrOXYzine HCl 25 MG Oral Tablet | PSN | f84e3365-57d2-4904-9275-96600f8d74c7 | 100 |
| 995258 | hydroxyzine hydrochloride 25 MG Oral Tablet | SCD | f84e3365-57d2-4904-9275-96600f8d74c7 | 100 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 71335-3035-1 | 71335303501 | 1000 TABLET, FILM COATED in 1 BOTTLE (71335-3035-1) | 2025-12-03 | No | No | Current |